PACTR202308547851267

Comparison of the effects of three agents used in the treatment of disease of the pulp in permanent posterior teeth in the Nigerian adult population

A comparative evaluation of three indirect pulp capping agents in the treatment of reversible pulpitis in permanent posterior teeth in Nigerian adult patient
Igweagu Chibuzor Emmanuel·Phase 3·Pan Africa Clinical Trials Registry·drugCompleted
Study focus
Disease/Condition
Oral Health
Intervention type
drug
Sponsor & location
Primary sponsor
Igweagu Chibuzor Emmanuel
Location
Nigeria
Timeline & enrollment
Phase
Phase 3
Start date
Jul 14, 2021
End date
Dec 19, 2022
Summary

Reversible pulpitis from deep carious lesion is a common disease entity in Dentistry worldwide. Indirect pulp capping is the recommended treatment. Calcium hydroxide has been the most common agent used in our environment. Newer agents are being developed and domesticated in other countries. It will be worthwhile to evaluate the newer agents against the commonly used in our environment. The study's objectives include1. To compare the clinical outcomes after treatment with calcium hydroxide, Mineral trioxide aggregate and Biodentine2. To compare the radiological outcomes following successful clinical outcomes with the same agents3. To compare the effects of age , gender and site of carious lesion on clinical outcomes

ICD-10 classifications
Diseases of oral cavity, salivary glands and jawsDry mouth, unspecifiedOral mucositis (ulcerative)Leukoplakia and other disturbances of oral epithelium, including tongueTeething syndrome
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202308547851267
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202308547851267 through Pure Global AI's free database. This Phase 3 trial is sponsored by Igweagu Chibuzor Emmanuel and is currently Completed. The study focuses on Oral Health.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.